25-Hydroxyvitamin D31α-hydroxylase expression in breast cancer and use of non-1α-hydroxylated vitamin D analogue
Ulrika Segersten(Uppsala University), Gunnar Westin(Uppsala University Hospital), Pernille Holm(Leo Pharma (Denmark)), Per Hellman(Uppsala University Hospital), Lise Binderup(Leo Pharma (Denmark)), Hans Nordgren(Uppsala University Hospital), Peyman Björklund(Uppsala University), Göran Åkerström(Uppsala University Hospital), Ola Hessman(Västerås Municipality)
Cited by 71
Related Papers
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism
|Nature Genetics|2013|621
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
|Circulation|2009|414